Toremifene Citrate
3 NDCs across 3 manufacturers|2 Generic,1 Brand
Toremifene Citrate is used to treat breast neoplasms and hormone-dependent neoplasms, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on May 29, 1997, and the first generic was approved Dec 4, 2018. FDA's Orange Book lists 2 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $912K on Toremifene Citrate across 953 claims for 169 beneficiaries.
Toremifene Citrate is available as 3 NDCs from 3 manufacturers (2 generic, 1 brand), with NADAC prices from $21.13 to $41.13 per EA — a 95% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
3
2G / 1B
Manufacturers
3
competing in market
Price Spread
$21.13 – $41.13
per EA
7d Activity
avg -6.8% WoW · of 3 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
3 manufacturers producing TOREMIFENE CITRATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
FARESTON 60 MG TABLET | $41.1265 per EA | — |
TOREMIFENE CITRATE 60 MG TAB | $21.1319 per EA | -6.76% |
TOREMIFENE CITRATE 60 MG TAB | $21.1319 per EA | -6.76% |
Frequently Asked Questions
What is Toremifene Citrate used to treat?
Toremifene Citrate is used to treat breast neoplasms and hormone-dependent neoplasms, per the National Library of Medicine's MED-RT classification.
When did Toremifene Citrate become available as a generic?
FDA approved the first generic Toremifene Citrate (ANDA) on Dec 4, 2018. The Orange Book currently lists 2 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Toremifene Citrate?
In 2024, Medicare Part D spent $912K on Toremifene Citrate across 953 claims for 169 beneficiaries.
How many Toremifene Citrate products are on the market?
The Toremifene Citrate drug market contains 3 NDCs from 3 manufacturers — 2 generic and 1 brand product.
What is the price range for Toremifene Citrate?
NADAC reference prices for Toremifene Citrate range from $21.1319 to $41.1265 per EA — a 95% difference between cheapest and most expensive.
Is generic Toremifene Citrate cheaper than brand?
The average generic NADAC for Toremifene Citrate is $21.1319 per EA, versus $41.1265 for brand-labeled products — generic is about 49% cheaper on average.
Which manufacturers make Toremifene Citrate?
3 manufacturers list Toremifene Citrate in NADAC. Ranked by number of NDCs, the largest are Kyowa Kirin, Inc. (1), Rising Pharma Holdings Inc. (1), Novadoz Pharmaceuticals LLC (1).
How has the price of Toremifene Citrate changed recently?
Over the past 7 days, 0 Toremifene Citrate NDCs rose and 2 fell, with a market-wide average change of -6.8%.